Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Molecules ; 29(5)2024 Feb 29.
Artigo em Inglês | MEDLINE | ID: mdl-38474590

RESUMO

Lung cancer has the lowest survival rate due to its late-stage diagnosis, poor prognosis, and intra-tumoral heterogeneity. These factors decrease the effectiveness of treatment. They release chemokines and cytokines from the tumor microenvironment (TME). To improve the effectiveness of treatment, researchers emphasize personalized adjuvant therapies along with conventional ones. Targeted chemotherapeutic drug delivery systems and specific pathway-blocking agents using nanocarriers are a few of them. This study explored the nanocarrier roles and strategies to improve the treatment profile's effectiveness by striving for TME. A biofunctionalized nanocarrier stimulates biosystem interaction, cellular uptake, immune system escape, and vascular changes for penetration into the TME. Inorganic metal compounds scavenge reactive oxygen species (ROS) through their photothermal effect. Stroma, hypoxia, pH, and immunity-modulating agents conjugated or modified nanocarriers co-administered with pathway-blocking or condition-modulating agents can regulate extracellular matrix (ECM), Cancer-associated fibroblasts (CAF),Tyro3, Axl, and Mertk receptors (TAM) regulation, regulatory T-cell (Treg) inhibition, and myeloid-derived suppressor cells (MDSC) inhibition. Again, biomimetic conjugation or the surface modification of nanocarriers using ligands can enhance active targeting efficacy by bypassing the TME. A carrier system with biofunctionalized inorganic metal compounds and organic compound complex-loaded drugs is convenient for NSCLC-targeted therapy.


Assuntos
Fibroblastos Associados a Câncer , Carcinoma Pulmonar de Células não Pequenas , Neoplasias Pulmonares , Neoplasias , Humanos , Neoplasias Pulmonares/tratamento farmacológico , Carcinoma Pulmonar de Células não Pequenas/tratamento farmacológico , Sistemas de Liberação de Medicamentos , c-Mer Tirosina Quinase , Microambiente Tumoral , Neoplasias/tratamento farmacológico
2.
Antonie Van Leeuwenhoek ; 117(1): 4, 2023 Dec 28.
Artigo em Inglês | MEDLINE | ID: mdl-38153571

RESUMO

Naturally infected Channa punctata exhibiting bacterial septicemic syndrome including ulcerations along with mortality records were collected from a fish farm in Assam during winter season (early November 2020 to early January 2021). The moribund fishes were subjected for bacterial isolation followed by identification of the bacteria. Two dominant emerging bacterial pathogens were identified as Aeromonas veronii (isolate ZooGURD-01) and Aeromonas hydrophila (isolate ZooGURD-05) by standard biochemical characterization and 16S rRNA and rpo B gene amplification. Re-infection experiments of both the bacterial isolates in healthy disease-free C. punctata showed similar symptoms to that of natural infection thus confirming their virulence. The LD50 calculated during challenge test for both the isolates ZooGURD-01 and ZooGURD-05 found to be pathogenic at 2.6 × 104 and 1.6 × 104 CFU/fish respectively. Further PCR amplification of specific virulent genes (aerolysin, hemolysin and enterotoxin) confirmed pathogenicity for both isolates. Histopathological examinations of liver and kidney in re-infection experiments showed prominent changes supporting bacterial septicaemia. Antibiotic sensitivity pattern showed that the isolates ZooGURD-01 and ZooGURD-05 were sensitive to 22 and 19 out of 25 antimicrobials respectively. The present study was the first report on the mortality of farmed C. punctata associated with natural infection caused by A. veronii and A. hydrophila with no record of pathogenicity of A. veronii in C. punctata.


Assuntos
Aeromonas hydrophila , Channa punctatus , Animais , Aeromonas hydrophila/genética , Aeromonas veronii/genética , RNA Ribossômico 16S/genética , Reinfecção , Peixes
3.
J Fish Biol ; 99(2): 450-461, 2021 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-33759455

RESUMO

Mustura subhashi, new species, is described from the Dikal River, a north bank tributary of the Brahmaputra drainage in Arunachal Pradesh. It is distinguished from all its congeners by having a colour pattern of 14-23 dark-greyish black to dark brown irregular bars on a greyish to pale beige body; pre-dorsal bars thin, numerous, wider than interspaces, weakly contrasted, uniting dorsally at lateral one-third or midway on flank to form thicker bars, coalescing further at lateral one-fifth and continuous on dorsum with contralateral bars; bars below dorsal fin exhibiting similar condition but slightly wider than pre-dorsal bars; post-dorsal bars thicker than anterior bars, wider than interspaces, sharply contrasted, rarely coalescing on flank; and a short bar along the caudal mid-line, rarely forming a blotch. Based on re-examination of the type specimens and additional materials, Mustura dikrongensis is confirmed as a species belonging to Mustura, and M. harkishorei is not sufficiently diagnosed from 'Nemacheilus' corica.


Assuntos
Cipriniformes , Animais , Cipriniformes/genética , Índia , Rios
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA